Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
US6555569B2 · kind B2 · utility
6Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 2001 |
| Grant date | Apr 29, 2003 |
| Priority date | — |
| Expiry date | Feb 16, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition containing a glycogen phosphorylase inhibitor of Formula I or IA as defined herein is administered to a mammal to treat infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.